|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
6 April 2022 |
|
Main ID: |
JPRN-UMIN000002946 |
|
Date of registration:
|
28/12/2009 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The study comparing ezetimibe with pravastatin on expressions and activities of small GTP-binding proteins, and on endothelial function.
|
|
Scientific title:
|
The study comparing ezetimibe with pravastatin on expressions and activities of small GTP-binding proteins, and on endothelial function. - The study comparing ezetimibe with pravastatin on expressions and activities of small GTP-binding proteins, and on endothelial function. |
|
Date of first enrolment:
|
2009/12/01 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003581 |
|
Study type:
|
Interventional |
|
Study design:
|
Cross-over Randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Yoshihiro Fukumoto |
|
Address:
|
1-1, Seiryo-machi, Aoba-ku, Sendai-city
Japan |
|
Telephone:
|
022-717-7153 |
|
Email:
|
|
|
Affiliation:
|
Tohoku university graduate school of medicine Department of cardiovascular medicine |
|
|
Name:
|
Kotaro Nochioka |
|
Address:
|
1-1, Seiryo-machi, Aoba-ku, Sendai-city
Japan |
|
Telephone:
|
022-717-7153 |
|
Email:
|
nochioka@cardio.med.tohoku.ac.jp |
|
Affiliation:
|
Tohoku university graduate school of medicine Department of cardiovascular medicine |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Pregnant or possibly pregnant individuals.
Age minimum:
20years-old
Age maximum:
80years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Atherosclerotic cardiovascular diseases
|
|
Intervention(s)
|
Ezetimibe(10mg/day)
Pravastatin(10mg/day)
|
|
Primary Outcome(s)
|
Expressions and activities of small-GTP binding proteins
FMD(flow-mediated dilation)
|
|
Secondary Outcome(s)
|
Serum total and LDL cholesterol
Serum triglyceride
Cholesterol absorption and synthesis markers
Adiponectin
High sensitive CRP
|
|
Source(s) of Monetary Support
|
|
None
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
01/01/2011 |
|
URL:
|
|
|
|